December 2000

• Denke MA, Adams-Huet B, Nguyen AT.
  Individual cholesterol variation in response to a margarine- or butter-based diet: A study in families.
  JAMA. 2000 Dec 6;284(21):2740-7.

November 2000

• Kroll MH, Cole TG, Rifai N, Cooper G, Warnick GR, Jialal I.
  Standardization of lipoprotein reporting.
  Am J Clin Pathol. 2000 Nov;114(5):696-702.
• Denke MA.
  Nutritional and health benefits of beer.
  Am J Med Sci. 2000 Nov;320(5):320-6.

• Devaraj S, Hirany S, Jialal I.
  Ratio of remnant-like particle cholesterol to serum total triglycerides is a reliable screening test for type III dyslipidaemia.
  Ann Clin Biochem. 2000 Nov;37 ( Pt 6):790-1. No abstract available.

• O'Byrne D, Grundy S, Packer L, Devaraj S, Baldenius K, Hoppe PP, Kraemer K, Jialal I, Traber MG.
  Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans.
  Free Radic Biol Med. 2000 Nov 1;29(9):834-45.

October 2000

• Devaraj S, Jialal I.
  Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.
  Free Radic Biol Med. 2000 Oct 15;29(8):790-2.
• Garg A, Stray-Gundersen J, Parsons D, Bertocci LA.
  Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy.
  Diabetes Care. 2000 Oct;23(10):1545-50.
• Grundy SM.
  Metabolic complications of obesity.
  Endocrine. 2000 Oct;13(2):155-65. Review.

July 2000

• Grundy SM.
  Early detection of high cholesterol levels in young adults.
  JAMA. 2000 Jul 19;284(3):365-7. No abstract available.
• Devaraj S, Jialal I.
  Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.
  Circulation. 2000 Jul 11;102(2):191-6.
• O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr, Forrester JS, Douglas PS, Faxon DP, Fisher JD, Gregoratos G, Hochman JS, Hutter AM Jr, Kaul S, Wolk MJ.
  American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.
  Circulation. 2000 Jul 4;102(1):126-40. Review. No abstract available.
• Devaraj S, Jialal I.
  Antioxidants and vitamins to reduce cardiovascular disease.
  Curr Atheroscler Rep. 2000 Jul;2(4):342-51. Review.
• O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr.
  American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.
  J Am Coll Cardiol. 2000 Jul;36(1):326-40. Review. No abstract available.

June 2000

• Jialal I, Devaraj S.
  Vitamin E supplementation and cardiovascular events in high-risk patients.
  N Engl J Med. 2000 Jun 22;342(25):1917-8. No abstract available.
• Cater NB
  Plant stanol ester: review of cholesterol-lowering efficacy and implications for coronary heart disease risk reduction.
  Prev Cardiol. 2000 Summer;3(3):121-130.

May 2000

• Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ.
  Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.
  N Engl J Med. 2000 May 11;342(19):1392-8.
• Valentine RJ, Verstraete R, Clagett GP, Cohen JC.
  Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis.
  Arch Intern Med. 2000 May 8;160(9):1343-8.
• Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I.
  Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
  Atherosclerosis. 2000 May;150(1):217-24.
• Hirany S, O'Byrne D, Devaraj S, Jialal I.
  Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease.
  Clin Chem. 2000 May;46(5):667-72.
• Garg A.
  Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).
  J Clin Endocrinol Metab. 2000 May;85(5):1776-82.
• Abate N.
  Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.
  J Diabetes Complications. 2000 May-Jun;14(3):154-74. Review.

February 2000

• Grundy SM.
  Cholesterol management in the era of managed care.
  Am J Cardiol. 2000 Feb 10;85(3A):3A-9A. Review.
• Garg A.
  Lipodystrophies.
  Am J Med. 2000 Feb;108(2):143-52. Review.
• Jialal I, Abate N.
  Therapy and clinical trials.
  Curr Opin Lipidol. 2000 Feb;11(1):93-7. Review. No abstract available.

January 2000

• Smith SC Jr, Greenland P, Grundy SM.
  AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.
  Circulation. 2000 Jan 4-11;101(1):111-6. No abstract available.
• Toto RD, Grundy SM, Vega GL.
  Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
  Am J Nephrol. 2000 Jan-Feb;20(1):12-7.